← Leaderboards
Paul Lafferty
Vrx Medical Inc.
$303,366
Attributed
$303,366
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $250.6K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$303,366 · 1
By mechanism
R43$303,366 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Degenerative Polyarthritis”
- Hang Lin · University Of Pittsburgh At Pittsburgh$6,336,554
- Birgit Schilling · Medical College Of Wisconsin$5,864,187
- Matlock Jeffries · University Of Oklahoma Hlth Sciences Ctr$5,497,703
- Chang Hun Lee · Columbia University Health Sciences$5,341,536
- Feliks Kogan · Stanford University$4,914,640
- Steven P Cohen · Johns Hopkins University$4,637,929
Research focus
Degenerative PolyarthritisDesignComplex Regional Pain SyndromesCostAmericanAffectAccountingArthralgiaArthritic PainAlternative TherapiesAugmented RealityBaseBase Of The BrainAnalgesicsBrainAdultChronicChronic PainChronic Pain PatientClinical ResearchClinical TrialsArthritisCommercializationDiagnosis